
Keywords: ACN, acetonitrile; AOP, adverse outcome pathway; BQ, benzoquinone; CDNB, 1-chloro-2,4-dinitrobenzene; COUM, coumarin; Cys-DPRA, cysteine-direct peptide reactivity assay; DBN, 1,5-diazabicyclo[4.3.0]non-5-ene; DCYA, dansyl cysteamine; (DCYA)2, dansyl cyste